Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141762 · ClinicalTrials.gov registry record
Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study
A clinical trial, sponsored by University of Melbourne.
- Completed
- Registry status
- 100
- Enrollment target
NCT03141762: Completed study, sponsored by University of Melbourne.
NCT03141762 is a clinical trial that has completed, run by University of Melbourne. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03141762 has completed, sponsored by University of Melbourne.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study
Primary Outcome
12-monthly falls calendar - This will record time to first fall, falls, incidence, number of falls including injurious falls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2020-09-20 |
What the finished NCT03141762 record still lists
NCT03141762 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03141762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03141762 about?
NCT03141762 is a clinical study titled "Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study". Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study
What is the current status of trial NCT03141762?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-05-03. Estimated completion is 2020-09-20.
Who is sponsoring clinical trial NCT03141762?
This trial is sponsored by University of Melbourne, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI